Erratum: Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: A 6 year follow-up study-CORRIGENDUM (Psychological Medicine (2012) doi: 10.1017/S0033291712001948);Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: A 6-year follow-up study

Psychological Medicine

Volumn 43, Issue 6, 2013, Pages 1187-1196

  Mora, E ^a   Portella, M J ^b   Forcada, I ^a   Vieta, E ^c   Mur, M ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; cognition; follow up study; lithium treatment; psychosocial functioning

Indexed keywords

LITHIUM DERIVATIVE; TRANQUILIZER;

ADULT; ATTENTION; BIPOLAR DISORDER; CASE CONTROL STUDY; COGNITIVE DEFECT; EMPLOYMENT; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN RELATION; INHIBITION (PSYCHOLOGY); MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; TREATMENT OUTCOME; ARTICLE; PSYCHOLOGICAL ASPECT;

ADULT; ANTIMANIC AGENTS; ATTENTION; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COGNITION DISORDERS; EMPLOYMENT; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INHIBITION (PSYCHOLOGY); INTERPERSONAL RELATIONS; LITHIUM COMPOUNDS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 84877744239     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713002146     Document Type: Erratum

References (51)

1. Arts B, Jabben N, Krabbendam L, van Os J (2008). Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychological Medicine 38, 771-785.
2. Balanzá-Martinez V, Tabarés-Seisdedos R, Selva-Vera G, Martinez-Arán A, Torrent C, Salazar-Fraile J, Leal-Cercós C, Vieta E, Gómez-Beneyto M (2005). Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients : A 3-year follow-up study. Psychotherapy and Psychosomatics 74, 113-119.
3. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS (2011). Pathways underlying neuroprogression in bipolar disorder : Focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews 35, 804-817.
4. Bonnin CM, Martinez-Arán A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E (2010). Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients : A long-term, followup study. Journal of Affective Disorders 121, 156-160.
5. Bora E, Vahip S, Akdeniz F, Gonul AS, Eryavuz A, Ogut M, Alkan M (2007). The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disorders 9, 468-477.
6. Bora E, Yucel M, Pantelis C (2009). Cognitive endophenotypes of bipolar disorder : A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. Journal of Affective Disorders 113, 1-20.
7. Burdick KE, Goldberg JF, Harrow M (2010). Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up. Acta Psychiatrica Scandinavica 122, 499-506.
8. Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK (2006). Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. Journal of Nervous and Mental Diseases 194, 255-260.
9. Clark L, Iversen SD, Goodwin GM (2002). Sustained attention deficit in bipolar disorder. British Journal of Psychiatry 180, 313-319.
10. Conners C (2000). Conners Continuous Performance Test II Manual. Multi-Health Systems Inc. : Toronto.
11. Dean BB, Gerner D, Gerner RH (2004). A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Current Medical Research Opinion 20, 139-154.
12. Delis DC, Kramer JH, Kaplan E, Ober BA (1987). The California Verbal Learning Test Manual. Psychological Corp. : New York, NY.
13. Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F (2009). Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disorders 11, 663-671.
14. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S (2003). The Maudsley Bipolar Disorder Project : The effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. Journal of Clinical Psychiatry 64, 86-93.
15. Engelsmann F, Katz J, Ghadirian AM, Schachter D (1988). Lithium and memory: A long-term follow-up study. Journal of Clinical Psychopharmacology 8, 207-212.
16. Gildengers AG, Mulsant BH, Begley A, Mazumdar S, Hyams AV, Reynolds III CF, Kupfer DJ, Butters MA (2009). The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disorders 11, 744-752.
17. Goodwin G, Vieta E (2005). Effective maintenance treatment -breaking the cycle of bipolar disorder. European Psychiatry 20, 365-371.
18. Goswami U, Sharma A, Khastigir U, Ferrier IN, Young AH, Gallagher P, Thompson JM, Moore PB (2006). Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. British Journal of Psychiatry 188, 366-373.
19. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56-62.
20. Heaton R (1981). The Wisconsin Card Sorting Test Manual. Psychological Assessment Resources : Odessa, TX.
21. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-SantAnna M, Klamt F, Moreira JC, de Bittencourt Pasquali MA, Fries GR, Quevedo J, Gama CS, Post R (2011). Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatry Research 45, 156-161.
22. Kauer-SantAnna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009). Brainderived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. International Journal of Neuropsychopharmacology 12, 447-458.
23. Kurtz MM, Gerraty RT (2009). A meta-analytic investigation of neurocognitive deficits in bipolar illness : Profile and effects of clinical state. Neuropsychology 23, 551-562.
24. López-Jaramillo C, Lopera-Vásquez J, Ospina-Duque J, Garcia J, Gallo A, Cortez V, Palacio C, Torrent C, Martinez-Arán A, Vieta E (2010). Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. Journal of Clinical Psychiatry 71, 1055-1060.
25. Maj M, Pirozzi R, Magliano L, Bartoli L (1998). Long-term outcome of lithium prophylaxis in bipolar disorder : A 5-year prospective study of 402 patients at a lithium clinic. American Journal of Psychiatry 155, 30-35.
26. Mann-Wrobel MC, Carreno JT, Dickinson D (2011). Metaanalysis of neuropsychological functioning in euthymic bipolar disorder : An update and investigation of moderator variables. Bipolar Disorders 13, 334-342.
27. Martinez-Arán A, Torrent C, Solé B, Bonnin CM, Rosa AR, Sánchez-Moreno J, Vieta E (2011). Functional remediation for bipolar disorder. Clinical Practice and Epidemiology in Mental Health 7, 112-116.
28. Martinez-Arán A, Vieta E, Colom F, Torrent C, Reinares M, Goikolea JM, Benabarre A, Comes M, Sánchez-Moreno J (2005). Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairmentPsychotherapy and Psychosomatics 74, 295-302.
29. Martinez-Arán A, Vieta E, Colom F, Torrent C, Sánchez- Moreno J, Reinares M, Benabarre A, Goikolea JM, Brugué E, Daban C, Salamero M (2004a). Cognitive impairment in euthymic bipolar patients : Implications for clinical and functional outcome. Bipolar Disorders 6, 224-232.
30. Martinez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sánchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M (2004b). Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. American Journal of Psychiatry 161, 262-270.
31. Martino DJ, Marengo E, Igoa A, Scapola M, Ais ED, Perinot L, Strejilevich SA (2009). Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders : A prospective 1 year follow-up study. Journal of Affective Disorders 116, 37-42.
32. Meyers JE, Meyers KR (1995). Rey Complex Figure Test and Recognition Trial. Psychological Assessment Resources
33. Odessa, FL. Moorhead TW,McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM (2007). Progressive gray matter loss in patients with bipolar disorder. Biological Psychiatry 62, 894-900.
34. Mur M, Portella MJ, Martinez-Arán A, Pifarré J, Vieta E (2007). Persistent neuropsychological deficit in euthymic bipolar patients : Executive function as a core deficit. Journal of Clinical Psychiatry 68, 1078-1086.
35. Mur M, Portella MJ, Martinez-Arán A, Pifarré J, Vieta E (2008). Long-term stability of cognitive impairment in bipolar disorder : A 2-year follow-up study of lithiumtreated euthymic bipolar patients. Journal of Clinical Psychiatry 69, 712-719.
36. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E (2009). Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients. Psychopathology 42, 148-156.
37. OShea R, Poz R, Michael A, Berrios GE, Evans JJ, Rubinsztein JS (2010). Ecologically valid cognitive tests and everyday functioning in euthymic bipolar disorder patients. Journal of Affective Disorders 125, 336-340.
38. Reitan R (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills 8, 271-276.
39. Robinson LJ, Ferrier IN (2006). Evolution of cognitive impairment in bipolar disorder : A systematic review of cross-sectional evidence. Bipolar Disorders 8, 103-116.
40. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, Moore PB (2006). A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. Journal of Affective Disorders 93, 105-115.
41. Rosa AR, Bonnin CM, Vázquez GH, Reinares M, Solé B, Tabarés-Seisdedos R, Balanzá-Martinez V, González-Pinto A, Sánchez-Moreno J, Vieta E (2010). Functional impairment in bipolar II disorder : Is it as disabling as bipolar I Journal of Affective Disorders 127, 71-76.
42. Rosa AR, Sánchez-Moreno J, Martinez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, Kapczinski F, Vieta E (2007). Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clinical Practice and Epidemiology in Mental Health 3, 5.
43. Savitz J, Solms M, Ramesar R (2005). Neuropsychological dysfunction in bipolar affective disorder : A critical opinion. Bipolar Disorders 7, 216-235.
44. Solé B, Bonnin CM, Torrent C, Balanzá-Martinez V, Tabarés-Seisdedos R, Popovic D, Martinez-Arán A, Vieta E (2012). Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatrica Scandinavica 125, 309-317.
45. Solé B, Martinez-Aran A, Torrent C, Bonnin CM, Reinares M, Popovic D, Sánchez-Moreno J, Vieta E (2011). Are bipolar II patients cognitively impaired A systematic review. Psychological Medicine 41, 1791-1803.
46. Spreen O, Strauss E (1998). A Compendium of Neuropsychological Tests. Oxford University Press : New York. Tabarés-Seisdedos R, Balanzá-Martinez V, Sanchez-Moreno J, Martinez-Aran A
47. Salazar-Fraile J, Selva-Vera G, Rubio C, Mata I, Gómez-Beneyto M, Vieta E (2008). Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. Journal of Affective Disorders 109, 286-299.
48. Torres IJ, Boudreau VG, Yatham LN (2007). Neuropsychological functioning in euthymic bipolar disorder : A meta-analysis. Acta Psychiatrica Scandinavica Supplementum, issue 434, 17-26.
49. Wechsler D (2001). Wechsler Adult Intelligence Scale-III : Technical Manual (Spanish Version). TEA: Madrid.
50. Wingo AP, Harvey PD, Baldessarini RJ (2009). Neurocognitive impairment in bipolar disorder patients : Functional implications. Bipolar Disorders 11, 113-125.
51. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: Reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435.